MLYS - Balance Sheet - Mineralys Therapeutics, Inc.

Current Liabilities	14.6 M
Accounts Payable	479 K
Short-Term Debt	0
Other Current Liabilities	14.2 M
Non-Current Liabilities	0
Long-Term Debt	0
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020
ASSETS
Cash & Cash Equivalents	114.1	49.3	87.7	10.6	1.4
Short Term Investments	84.1	187.3	22.4	0	0
Receivables	0	0	0	0	0
Inventory	0	0	0	0	0
Other Current Assets	7.2	12.5	2.7	0.5	57 K
Total Current Assets	205.4	249.1	110.1	11.1	1.5
PP&E	53 K	0	0	0	0
Intangible Assets	0	0	0	0	0
Goodwill	0	0	0	0	0
Long Term Investments	0	2.5	0	0	0
Other Long Term Assets	0.5	51 K	4.3	3 K	20 K
Other Assets	0	0	0	0	0
Total Assets	205.9	251.6	114.4	11.1	1.5
LIABILITIES
Accounts Payable	0.5	0.6	1.9	0.8	0.5
Short Term Debt	0	0	0	0	4.5
Other Current Liabilities	14.2	9.9	6.2	4.3	54 K
Total Current Liabilities	14.6	10.5	8.1	5.1	5.1
Long Term Debt	0	0	0	0	0
Deferred Tax Income	0	0	0	0	0
Other Liabilities	0	0	0	0	0
Total Liabilities	14.6	10.5	166.7	34.0	5.1
EQUITY
Common Stock	5 K	4 K	1 K	1 K	1 K
Retained Earnings	(302.5)	(124.7)	(52.8)	(23.0)	(3.6)
Other Accumulative Comprehensive Income/Loss	0	0	(158.6)	0	0
Total Equity	191.3	241.2	(52.3)	(22.9)	(3.6)
Total Liabilities and Equity	205.9	251.6	114.4	11.1	1.5
SHARES OUTSTANDING
Common Shares Outstanding	48.5	36.2	40.9	39.1	39.1

Free